Gene · 4016
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis. | Genes Dis | 2023 | 37396555 | PubTator, text mining | PubMed |
| LOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction]. | Onco Targets Ther | 2023 | 37396313 | PubTator, text mining | PubMed |
| Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork. | Eur J Pharmacol | 2023 | 37391006 | PubTator, text mining | PubMed |
| Super-enhancer-driven lncRNA LIMD1-AS1 activated by CDK7 promotes glioma progression. | Cell Death Dis | 2023 | 37385987 | PubTator, text mining | PubMed |
| Reviewing Atrial Fibrillation Pathophysiology from a Network Medicine Perspective: The Relevance of Structural Remodeling, Inflammation, and the Immune System. | Life (Basel) | 2023 | 37374146 | PubTator, text mining | PubMed |
| Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression. | Biomedicines | 2023 | 37371692 | PubTator, text mining | PubMed |
| Emerging trends on the mechanism of pelvic organ prolapse from 1997 to 2022: visualization and bibliometric analysis. | Front Med (Lausanne) | 2023 | 37351071 | PubTator, text mining | PubMed |
| Identification of molecular mechanisms causing skin lesions of cutaneous leishmaniasis using weighted gene coexpression network analysis (WGCNA). | Sci Rep | 2023 | 37330553 | PubTator, text mining | PubMed |
| Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia. | Drug Des Devel Ther | 2023 | 37305402 | PubTator, text mining | PubMed |
| Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients. | Genes Genomics | 2023 | 37301776 | PubTator, text mining | PubMed |
| Identification of several inflammation-related genes based on bioinformatics and experiments. | Int Immunopharmacol | 2023 | 37301122 | PubTator, text mining | PubMed |
| New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins. | Molecules | 2023 | 37298909 | PubTator, text mining | PubMed |
| Clinical, Histological, and Molecular Prognostic Factors in Childhood Medulloblastoma: Where Do We Stand? | Diagnostics (Basel) | 2023 | 37296767 | PubTator, text mining | PubMed |
| Is There an Association Between Pseudoexfoliation and Pterygium? An Observational Study in a Semi-arid District of South India. | Cureus | 2023 | 37288233 | PubTator, text mining | PubMed |
| LOXL1-AS1/miR-761/PTEN as a Novel Signaling Pathway in Myocardial Ischemia and Reperfusion Injury (MIRI): Epigenetic Regulation by Long Non-Coding RNA (LncRNA) in MIRI. | Korean Circ J | 2023 | 37271745 | PubTator, text mining | PubMed |
| Long-Term Evaluation of Pseudoexfoliation Syndrome Post-Cataract Extraction. | J Pers Med | 2023 | 37240988 | PubTator, text mining | PubMed |
| Pseudoexfoliation Syndrome-Clinical Characteristics of Most Common Cause of Secondary Glaucoma. | J Clin Med | 2023 | 37240686 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Induced by Erythropoietin Receptor Overexpression in Rat Mammary Adenocarcinoma RAMA 37-28 Cells. | Int J Mol Sci | 2023 | 37239828 | PubTator, text mining | PubMed |
| LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung. | Sci Adv | 2023 | 37235663 | PubTator, text mining | PubMed |
| Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications. | Front Oncol | 2023 | 37234990 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4016/papers?page=11